Enfusion, which provides cloud-based investment management software, filed on Friday with the SEC to raise up to $100 million in an initial public offering.
Enfusion is a SaaS provider focused on the investment management industry. Its solution simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset, allowing clients to see and interact with all parts of the investment management lifecycle ranging from portfolio construction, trading, risk management, accounting, and operations through to investor reporting seamlessly in real time, in one screen. As of June 30, 2021, Enfusion had 635 global clients.
The Chicago, IL-based company was founded in 1995 and booked $93 million in revenue for the 12 months ended June 30, 2021. It plans to list on the NYSE under the symbol ENFN. Enfusion filed confidentially on July 1, 2021. Morgan Stanley, Goldman Sachs, BofA Securities, Credit Suisse, Piper Sandler, Stifel, and William Blair are the joint bookrunners on the deal. No pricing terms were disclosed.
